Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gonzalo García González"'
Autor:
Mercedes Durán Domínguez, Alejandro González Morales, Blanca Ascensión Hernando Fernández-Aránguiz, Cooperative group: Burgos-Valladolid-Madrid, Enrique Lastra Aras, Gonzalo García González, Guillermo Crespo Herrero, Iria Gallego Gallego, Laura Ortega Morán, Mª del Mar Infante Sanz, Patricia Saiz López
Publikováno v:
Annals of Clinical Oncology. :1-7
Background: In patients with advanced high-grade serous ovarian cancer (HGSOC) and prostate adenocarcinoma, the identification of somatic/germline BRCA1/2 mutations allows new therapeutic opportunities. To estimate the prevalence of somatic and germl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02bcf5a84617b9813cc844d29cf51488
https://doi.org/10.31487/j.aco.2020.02.01
https://doi.org/10.31487/j.aco.2020.02.01
Autor:
Javier Soto Alsar, Andres J. Muñoz Martín, Gonzalo García González, Aitana Calvo Ferrándiz, Marta Arregui Valles, Pilar García-Alfonso, Manuel Alva Bianchi, Marianela Bringas Beranek, Miguel Martín, Gabriela Torres Pérez-Solero, Inmaculada Aparicio Salcedo, Montserrat Blanco-Codesido, Laura Ortega, Iria Gallego Gallego, Natalia Gutiérrez Alonso
Publikováno v:
Journal of Clinical Oncology. 38:4041-4041
4041 Background: Approximately 25% of patients with colorectal cancer (CRC) debut with metastatic disease. In addition, 25-35% of patients with localized disease at diagnosis develop metastatic lesions during the evolution of their disease. Consequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c5fa3ef4c483ce926fcb4bfe1f9e986
https://doi.org/10.1200/jco.2020.38.15_suppl.4041
https://doi.org/10.1200/jco.2020.38.15_suppl.4041
Autor:
Gonzalo García González, Gabriela Torres Pérez-Solero, Laura Ortega, Pilar García-Alfonso, Inmaculada Aparicio Salcedo, Miguel Martín, Iria Gallego Gallego, Andres J. Muñoz Martín, Manuel Alva Bianchi, Aitana Calvo Ferrándiz, Montserrat Blanco-Codesido, Marta Arregui Valles
Publikováno v:
Journal of Clinical Oncology. 38:49-49
49 Background: Elderly patients with mCRC are underrepresented in clinical trials. For this reason, the optimal treatment in this population is uncertain. The aim of this study is to compare efficacy and safety outcomes in patients with mCRC treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03874ae7d57b9f6dc7fc71dec0a87d0c
https://doi.org/10.1200/jco.2020.38.4_suppl.49
https://doi.org/10.1200/jco.2020.38.4_suppl.49
Autor:
Íñigo Martínez Delfrade, Natalia Gutiérrez Alonso, Javier Soto Alsar, Gema Aguado Orihuela, Blanca Morón García, Montserrat Blanco-Codesido, Iria Gallego Gallego, Laura Ortega Morán, Carmen Sandoval García, Aitana Calvo Ferrándiz, Victoria Tirado Anula, Marianela Bringas Beranek, Pilar García-Alfonso, Andres J. Muñoz Martín, Gonzalo García González, María de Toro Carmena, Gabriela Torres Pérez-Solero, Iker Aguilar Caballero, Miguel Martín
Publikováno v:
Journal of Clinical Oncology. 37:e15136-e15136
e15136 Background: A recent study has suggested that KRAS mutation could increase the risk of VTE in patients with CRC. The role of others biomarkers, such as BRAF, in this setting is unknown. The aim of this study is to analyze the incidence of canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1fd6049abe5c6e34b77258f2845bf2c
https://doi.org/10.1200/jco.2019.37.15_suppl.e15136
https://doi.org/10.1200/jco.2019.37.15_suppl.e15136
Autor:
de Mena Miriam Lobo, Isabel Peligros, Ana Belen Ruperez, Miguel Martín, Beatriz Puente, Carmen Sandoval, Ana Corcuera, Isabel Echavarria, Montserrat Blanco-Codesido, Iria Gallego Gallego, Andrés Muñoz, Gonzalo García González, Gema Aguado, Aitana Calvo, Pilar Alfonso
Publikováno v:
Annals of Oncology. 28:iii94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dc3bc89f29203fe5d5240b94d189267
https://doi.org/10.1093/annonc/mdx261.268
https://doi.org/10.1093/annonc/mdx261.268